Medical/Pharmaceuticals
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances
* Complete data from global Phase III ZIRCON study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium (ASCO GU) inFebruary 2023 * Telix pipeline...
2022-12-22 06:04
3379
Medidata awarded International Innovation Award for Medidata Sensor Cloud
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- For the third consecutive year, Medidata, a Dassault Systèmes company, was awarded the International Innovation Award. This year, the Medidata Sensor Cloud won the award under the Service and Solution category. Sensor Cloud provides cutting-edge data inges...
2022-12-21 14:44
2742
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Dec. 21, 2022 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first patient treated in its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinic...
2022-12-21 09:00
3515
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned
HANGZHOU and SHAOXING, China, Dec. 21, 2022 /PRNewswire/ -- The enrollment of the 52-week Phase II clinical trial of thyroid hormone receptor β (THRβ) agonist ASC41 developed in house by Gannex Pharma Co., Ltd., a wholly owned subsidiary of Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), for tr...
2022-12-21 08:00
4127
Sirnaomics Announces Interim Data from Phase I Clinical Trial of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors
First three out of five cohorts pass safety requirements, allowing the Company to dose additional cohorts to assess safety, tolerability, pharmacokinetics and anti-tumor activity HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Dec. 21, 2022 /PRNewswire/ -- Sirnaomics Ltd.(Stock Code: 2257.HK) (th...
2022-12-21 00:39
4793
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
CAMARILLO, Calif., Dec. 21, 2022 /PRNewswire/ -- Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio c...
2022-12-21 00:06
2888
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health –Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-p...
2022-12-20 23:16
3036
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) and the Australian Therapeutic ...
2022-12-20 20:00
4008
Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.
GOTHENBURG, Sweden, Dec. 20, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong,Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for ...
2022-12-20 00:35
2103
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination
Carrick to execute Phase 2 clinical trial in patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer DUBLIN and FLORENCE, Italy, Dec. 19, 2022 /PRNewswire/ -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapie...
2022-12-19 23:07
3610
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma
2022-12-19 22:00
2928
Health and Hydrogen launches one of the first medical-grade Molecular Hydrogen Inhalation Machine HAH-301
GURGAON, India, Dec. 19, 2022 /PRNewswire/ -- Molecular Hydrogen Inhalation
therapy is now extensively used for its many health benefits, such as reducing
inflammation, improving cellular function, and protecting against oxidative
stress.Health And Hydrogen
2022-12-19 21:01
4898
China and ASEAN Deepened Exchanges and Cooperation on Traditional Medicine
BEIJING, Dec. 19, 2022 /PRNewswire/ -- A report from CRIOnline: From December 11 to 13, the 7th China-ASEAN Forum on Traditional Medicine was held in Fangchenggang City,Guangxi, China. China-ASEAN Forum on Traditional Medicine is held every two years. With the theme of "Seizing RCEP Opportunitie...
2022-12-19 20:01
3582
Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives
--The issue date of the patent will be January 3, 2023 by the United States Patent and Trademark Office (USPTO). The patent number is 11,541,071 -- The issued patent covers ASC10 and its derivatives, and their uses to treat virus infections including SARS-CoV-2, monkeypox virus and respiratory s...
2022-12-19 18:10
4135
Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans
The prevalence of cardiovascular and oncology diseases and the shortage of radiologists have boosted the development of innovative MRI technologies SAN ANTONIO, Dec. 19, 2022 /PRNewswire/ -- The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open...
2022-12-19 16:12
2286
SmartFuture Launches First Responder Platform
SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- As a key addition to its portfolio of Remote Patient Monitoring (RPM) solutions, SmartFuture has launched a First Responder Platform. This is an integrated solution designed for rapid response through real time monitoring of health vitals, doctor consultat...
2022-12-19 16:09
2861
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, fr...
2022-12-19 13:53
4619
'NCDs in Focus Act Now' Summit organized by Viatris
The summit aimed to build synergies between healthcare professions and policy makers, addressing the challenges in the management of NCDs inSoutheast Asia BANGKOK, Dec. 19, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS): The 'NCDs in Focus Act Now' Summit was recently organised by global health...
2022-12-19 09:30
3258
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
* Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform * Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Gra...
2022-12-16 19:56
4390
Possible Breakthrough in Cardiovascular Disease Diagnostics for Southeast Asia
SINGAPORE, Dec. 16, 2022 /PRNewswire/ -- Neuome Peptides Pte. Ltd., a Singapore
-based company has established an assay-developmentplatform, powered by machine
learning and novel, patented algorithms for the quantifiable detection of
biomarkers.
2022-12-16 16:03
3595
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24
Most Read
RoboParty Unveils RP1, a High-Performance Full-Stack Open-Source Humanoid Robot at IROS
2026-10-04 00:56
10600
Nuix Neo Generative AI Framework
2026-10-08 08:02
9072
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8074
